Jonas Bergh
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 259
- HER2/EGFR in Cancer Research 70
- Cancer Treatment and Pharmacology 62
- Cancer Cells and Metastasis 37
- Cancer-related Molecular Pathways 30
- Cancer Research 188
- Breast Cancer Treatment Studies 138
- Cancer Genomics and Diagnostics 45
- Co-authors
- Lars Holmberg (20 shared papers)Hans Nordgren (19 shared papers)Johanna Smeds (17 shared papers)Mauro Delorenzi (13 shared papers)Martine Piccart (16 shared papers)Lance D. Miller (15 shared papers)Per Hall (25 shared papers)Yudi Pawitan (14 shared papers)
- Journals
- Journal of Clinical Oncology (52 papers)Annals of Oncology (34 papers)Acta Oncologica (29 papers)Cancer Research (29 papers)Breast Cancer Research and Treatment (24 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Jonas Bergh
512 papers receiving 28.8k citations
Jonas Bergh's Hit Papers
Peers
Comparison fields: 5 of 175
- Cancer Research 9.4k
- Oncology 12.2k
- Molecular Biology 9.4k
- Pulmonary and Respiratory Medicine 3.6k
- Pathology and Forensic Medicine 1.7k
Countries citing papers authored by Jonas Bergh
This map shows the geographic impact of Jonas Bergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Bergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Bergh more than expected).
Fields of papers citing papers by Jonas Bergh
This network shows the impact of papers produced by Jonas Bergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Bergh. The network helps show where Jonas Bergh may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonas Bergh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 523 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis Hit paper breakdown → | 2006 | 1532 |
| 2 | 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years Hit paper breakdown → | 2017 | 1123 |
| 3 | An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Hit paper breakdown → | 2005 | 970 |
| 4 | Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer Hit paper breakdown → | 2006 | 845 |
| 5 | Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series Hit paper breakdown → | 2007 | 730 |
| 6 | Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Hit paper breakdown → | 2005 | 615 |
| 7 | Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade Hit paper breakdown → | 2007 | 603 |
| 8 | Identification of molecular apocrine breast tumours by microarray analysis Hit paper breakdown → | 2005 | 586 |
| 9 | Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing Hit paper breakdown → | 2018 | 579 |
| 10 | Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials Hit paper breakdown → | 2017 | 547 |
| 11 | Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer Hit paper breakdown → | 2006 | 544 |
| 12 | 2009 | 485 | |
| 13 | Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials Hit paper breakdown → | 2015 | 483 |
| 14 | 2008 | 466 | |
| 15 | 2006 | 441 | |
| 16 | An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression Hit paper breakdown → | 2017 | 417 |
| 17 | 2007 | 403 | |
| 18 | 1999 | 396 | |
| 19 | 2012 | 376 | |
| 20 | 2008 | 366 |
About Jonas Bergh
Jonas Bergh is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 523 papers that have together received 29.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (138 papers), HER2/EGFR in Cancer Research (70 papers), Cancer Treatment and Pharmacology (62 papers), Cancer Genomics and Diagnostics (45 papers), Advanced Breast Cancer Therapies (41 papers), Cancer Cells and Metastasis (37 papers), Estrogen and related hormone effects (34 papers) and Cancer-related Molecular Pathways (30 papers). The work is most often cited by research in Cancer Research (9.4k citations), Oncology (12.2k citations), Molecular Biology (9.4k citations), Pulmonary and Respiratory Medicine (3.6k citations) and Pathology and Forensic Medicine (1.7k citations). Jonas Bergh has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Lars Holmberg, Hans Nordgren, Johanna Smeds, Mauro Delorenzi, Martine Piccart, Lance D. Miller, Per Hall, Yudi Pawitan, Christos Sotiriou and Fátima Cardoso. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Acta Oncologica, Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.